AVM Biotech



AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.

Theresa A. Deisher, Ph.D.
Founder and Chief Science Officer
Janet R. Rea
Chief Operating Officer
Peter Jarzyna
Director of Lab Research

No teams yet!

No jobs yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.